123330 — Genic Co Balance Sheet
0.000.00%
- KR₩180bn
- KR₩185bn
- KR₩50bn
- 39
- 19
- 92
- 49
Annual balance sheet for Genic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,443 | 17,193 | 5,889 | 1,673 | 1,290 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,872 | 4,917 | 3,487 | 3,375 | 12,479 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 21,254 | 29,541 | 15,452 | 9,447 | 20,827 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 28,289 | 15,278 | 14,370 | 13,635 | 14,960 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 50,097 | 45,411 | 30,356 | 23,402 | 38,157 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17,568 | 15,700 | 14,254 | 11,699 | 15,277 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 27,766 | 26,113 | 14,413 | 11,870 | 16,003 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 22,331 | 19,297 | 15,943 | 11,531 | 22,154 |
Total Liabilities & Shareholders' Equity | 50,097 | 45,411 | 30,356 | 23,402 | 38,157 |
Total Common Shares Outstanding |